Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Berta Sanchez-Laorden

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
EMBO Molecular Medicine|February 14, 2022
Antifibrotic drugs as therapeutic tools in resistant melanomaBerta Sanchez-Laorden, M Angela Nieto
Cancer Cell|June 15, 2013
Mind the IQGAPBerta Sanchez-Laorden, Amaya Viros, Richard Marais
STAR Protocols|July 24, 2025
Protocol for generation, quantification, and phenotyping of brain metastases in preclinical mouse modelsFrancisco Javier Rodriguez-Baena, Berta Sanchez-Laorden
Open Biology|March 4, 2025
Schwann cells in regeneration and cancer: an epithelial-mesenchymal transition perspectiveFrancisco Gracia, Berta Sanchez-Laorden, Jose A Gomez-Sanchez
Cancer Cell|January 11, 2011
Oncogenic BRAF induces melanoma cell invasion by downregulating the cGMP-specific phosphodiesterase PDE5AImanol Arozarena, Berta Sanchez-Laorden, Leisl Packer, et al.
Oncogene|July 29, 2023
Microenvironmental Snail1-induced immunosuppression promotes melanoma growthMarta Arumi-Planas, Francisco Javier Rodriguez-Baena, Francisco Cabello-Torres, et al.
Cancer Cell|February 7, 2025
Microglial reprogramming enhances antitumor immunity and immunotherapy response in melanoma brain metastasesFrancisco Javier Rodriguez-Baena, Angel Marquez-Galera, Pablo Ballesteros-Martinez, et al.
Nature|June 12, 2014
Ultraviolet radiation accelerates BRAF-driven melanomagenesis by targeting TP53Amaya Viros, Berta Sanchez-Laorden, Malin Pedersen, et al.
The Journal of Investigative Dermatology|August 17, 2012
Topical 5-fluorouracil elicits regressions of BRAF inhibitor-induced cutaneous squamous cell carcinomaAmaya Viros, Robert Hayward, Matthew Martin, et al.
Cancer Discovery|September 27, 2014
The immune microenvironment confers resistance to MAPK pathway inhibitors through macrophage-derived TNFαMichael P Smith, Berta Sanchez-Laorden, Kate O'Brien, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
EMBO Molecular Medicine|February 14, 2022
Antifibrotic drugs as therapeutic tools in resistant melanomaBerta Sanchez-Laorden, M Angela Nieto
Cancer Cell|June 15, 2013
Mind the IQGAPBerta Sanchez-Laorden, Amaya Viros, Richard Marais
STAR Protocols|July 24, 2025
Protocol for generation, quantification, and phenotyping of brain metastases in preclinical mouse modelsFrancisco Javier Rodriguez-Baena, Berta Sanchez-Laorden
Open Biology|March 4, 2025
Schwann cells in regeneration and cancer: an epithelial-mesenchymal transition perspectiveFrancisco Gracia, Berta Sanchez-Laorden, Jose A Gomez-Sanchez
Cancer Cell|January 11, 2011
Oncogenic BRAF induces melanoma cell invasion by downregulating the cGMP-specific phosphodiesterase PDE5AImanol Arozarena, Berta Sanchez-Laorden, Leisl Packer, et al.
Oncogene|July 29, 2023
Microenvironmental Snail1-induced immunosuppression promotes melanoma growthMarta Arumi-Planas, Francisco Javier Rodriguez-Baena, Francisco Cabello-Torres, et al.
Cancer Cell|February 7, 2025
Microglial reprogramming enhances antitumor immunity and immunotherapy response in melanoma brain metastasesFrancisco Javier Rodriguez-Baena, Angel Marquez-Galera, Pablo Ballesteros-Martinez, et al.
Nature|June 12, 2014
Ultraviolet radiation accelerates BRAF-driven melanomagenesis by targeting TP53Amaya Viros, Berta Sanchez-Laorden, Malin Pedersen, et al.
The Journal of Investigative Dermatology|August 17, 2012
Topical 5-fluorouracil elicits regressions of BRAF inhibitor-induced cutaneous squamous cell carcinomaAmaya Viros, Robert Hayward, Matthew Martin, et al.
Cancer Discovery|September 27, 2014
The immune microenvironment confers resistance to MAPK pathway inhibitors through macrophage-derived TNFαMichael P Smith, Berta Sanchez-Laorden, Kate O'Brien, et al.
Pageof 2